Sr. Director - Strategic Alliances (SMDD) at Eli Lilly and Company

Indianapolis, Indiana, United States

Apply Now

Not SpecifiedCompensation

Senior (5 to 8 years), Expert & Leadership (9+ years)Experience Level

Full TimeJob Type

UnknownVisa

Pharmaceuticals, HealthcareIndustries

Requirements

Significant CMC (Chemistry, Manufacturing, and Controls) knowledge
Creativity, resilience, and business acumen
Collaborative, inclusive, and energetic leadership qualities
Ability to work cross-functionally within PRD and across external networks
Experience in strategic external partnerships, particularly with CDMOs for synthetic molecule design and development (SMDD)
Capability to provide leadership in governance with strategic external partners for drug substance and drug product development, characterization, and supply

Responsibilities

Implement and maintain strategic partnerships with external collaborators for rapid design and development of drug substance and drug product for pre-clinical/clinical phase assets, fostering collaboration and enabling seamless transitions across Discovery and Manufacturing organizations
Ensure alignment by working closely with cross-functional leaders across Lilly CMC, Quality, Procurement, and Safety to translate PRD/SMDD strategic requirements into actionable results with external partners
Drive implementation of novel technology by integrating with leadership and technical staff at CDMOs to transfer novel SMDD technology for GMP production and achieve speed and flawless execution
Champion operational excellence by monitoring capacity, quality, and performance in alignment with business contracts, performing trend analysis, and developing/driving governance of external operations with CDMOs

Skills

CMC

Synthetic Molecule Design

Drug Substance Development

Drug Product Development

Strategic Alliances

Cross-functional Leadership

Business Acumen

Pharmaceutical Development

Eli Lilly and Company

Develops and delivers prescription medicines globally

About Eli Lilly and Company

Eli Lilly and Company is a global pharmaceutical company that focuses on discovering, developing, and delivering medicines to improve health. The company has a long history of scientific achievements, including the creation of insulin, the first life-saving treatment for diabetes. Lilly's operations involve extensive research and development to create new medications and enhance existing ones, ensuring they are safe and effective. Their products are primarily prescription medicines sold to healthcare providers for various medical conditions, including diabetes, cancer, and pain management. What sets Lilly apart from its competitors is its strong commitment to ethical practices and the protection of its products from counterfeiting. The company's goal is to enhance lives through innovative medical solutions while maintaining high standards of quality and ethics.

Indianapolis, IndianaHeadquarters

1876Year Founded

$1,180.1MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Risks

Competition from Novo Nordisk's Ozempic may impact tirzepatide's market share.

Potential construction delays in Indiana could affect GLP-1 drug production timelines.

Regulatory challenges may hinder Kisunla's expansion in new Alzheimer's markets.

Differentiation

Eli Lilly's rich history includes the first life-saving insulin treatment.

Lilly's strategic partnerships enhance its position in neurodegenerative disease treatments.

FDA approval of Zepbound opens new therapeutic markets for sleep disorder treatments.

Upsides

Lilly's $9 billion complex in Indiana boosts GLP-1 drug production capacity.

Kisunla's approval in China expands Lilly's Alzheimer's treatment market in Asia.

Collaboration with EVA Pharma enhances Lilly's reputation as socially responsible.

Land your dream remote job 3x faster with AI

Try Jobo Free